Comprehensive ability evaluation and trend analysis of patients with malignant intracranial tumors in the perisurgery period.
Sign Up to like & getrecommendations! Published in 2021 at "Brain and behavior"
DOI: 10.1002/brb3.2192
Abstract: INTRODUCTION Prognostic situations differ in patients with malignant intracranial tumors. We focused on the quality of life, ability of daily living, and cognitive function of patients in the perisurgery period and investigated the correlation between… read more here.
Keywords: intracranial tumors; patients malignant; perisurgery period; ability ... See more keywords
Intracranial Primary Malignant Solitary Fibrous Tumor/Hemangiopericytoma Masquerading as Meningioma: Report of a Rare Case
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of General Medicine"
DOI: 10.2147/ijgm.s279483
Abstract: Background Intracranial solitary fibrous tumors/hemangiopericytomas (SFTs/HPCs) are rare spindle cell tumors originating from interstitial tissue that are usually benign. Primary malignant intracranial SFTs/HPCs are extremely rare. Here we describe a case of malignant intracranial SFT/HPC.… read more here.
Keywords: solitary fibrous; malignant intracranial; sfts hpcs; case ... See more keywords
Hypofractionated Gamma Knife Radiosurgery: Institutional Experience on Benign and Malignant Intracranial Tumors
Sign Up to like & getrecommendations! Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15661
Abstract: Background/Aim: We investigated the treatment outcomes and complications associated with hypofractionated GKRS for the treatment of benign and malignant intracranial tumors. Patients and Methods: Patients with intracranial tumors not candidate or refusing surgery were evaluated… read more here.
Keywords: gamma knife; benign malignant; knife radiosurgery; hypofractionated gamma ... See more keywords
Chemoresistance in Malignant Intracranial Tumors: Longer Survival with Negative MDR1 Expression.
Sign Up to like & getrecommendations! Published in 2020 at "Turkish neurosurgery"
DOI: 10.5137/1019-5149.jtn.29819-20.3
Abstract: AIM One challenge of malignant intracranial tumor (ICT) management is chemoresistance. Glutathione S-transferase (GST) and cytochrome p450 (CYP) are featured medicine degradation agents. MDR1, an outflow carrier, reduces drug accumulation into the multidrug-resistant cells. Our… read more here.
Keywords: expression; overall survival; malignant intracranial; negative mdr1 ... See more keywords